Hicuity Health Partner Expands Its Relationship with Sarah Bush Lincoln Health Center

New Service Relationship Builds on Existing Tele-ICU Partnership

Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, is expanding its relationship with Sarah Bush Lincoln with the implementation of inpatient telemetry services. Sarah Bush Lincoln has partnered with Hicuity Health for tele-ICU services since 2015. The success of this ongoing critical care collaboration influenced the decision to extend the partnership to include the new telemetry services.

Hicuity Health’s Remote Cardiac Telemetry monitoring provides hospitals with 24/7 monitoring by trained and certified telemetry technicians located in dedicated technology-enabled care centers. Hicuity’s nurse-managed technicians monitor cardiac at-risk patients throughout the hospital, identifying cardiac abnormalities, and then urgently reporting them to the bedside team. Partnering with Hicuity Health’s remote monitoring service engages trained monitoring of patient waveforms and allows bedside nurses to maintain their focus on patient care rather than focusing on computer monitors and responding to false alarms.

“As a tele-ICU partner, we have been impressed by Hicuity Health’s support and collaborative approach. The expansion of our relationship to include telemetry services is a direct result of our years of experience with Hicuity. Simply put, we wanted to ensure that we were working with a team that would be an expert partner to our clinical team,” Sandra Miller, SBL VP Patient Care Continuum, CNO, said. “The decision to expand the relationship to include remote telemetry services is a strategic decision from both an operational and clinical perspective.”

“We are pleased to extend our long-term relationship with Sarah Bush Lincoln to include telemetry services,” said Lou Silverman, Chief Executive Officer of Hicuity Health. “Its addition of Hicuity Health’s Remote Cardiac Telemetry services emphasizes the hospital’s commitment to providing its staff with the support needed to ensure high quality patient care.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.